E&B Devices is an early-stage medical device company. Their first product is a hands-free, no-prep screening device for colorectal cancer, and their pipeline includes devices for bladder cancer, fertility problems, and drug screening.
Lumenate MedicalLumenate Medical is developing a catheter-based cystoscope that lets non-urologist providers collect bladder images for remote review by board-certified urologists. Founded by a team that includes Johns Hopkins engineering and medical expertise, the Baltimore-based company is focused on shortening long waits for bladder cancer screening while keeping specialists in the decision-making loop. Its device remains in development and is not yet cleared or approved for sale by the U.S. Food and Drug Administration.
ScreenHERFounded by Purdue-trained mechanical engineer and medtech commercialization leader Jennifer Estep, ScreenHER is a women’s health diagnostics company focused on making earlier cervical cancer detection more accessible. Its first platform application, UriCerve™, is being developed for rapid, non-invasive use at the point of care so clinicians can make decisions during the same visit. UriCerve™ remains under development and is not approved for clinical use.
UE LifeSciences IncFounded in 2009, UE LifeSciences develops hand-held medical devices and digital tools that make early cancer detection more accessible, starting with its FDA-cleared iBreastExam for quick, painless, radiation-free breast-lump screening. Its Philadelphia-rooted, globally distributed team designs systems for community health workers and has supplied more than 2 million breast exams across 10 markets, with newer tools extending screening to cervical and oral cancer. The company also established an ISO 13485- and WHO-GMP-certified manufacturing facility in India as it expanded internationally.WEST CHESTER, PA
Lucid DiagnosticsLucid Diagnostics develops medical diagnostic tools for detecting esophageal precancer before it progresses to cancer, pairing its EsoGuard DNA test with the non-endoscopic EsoCheck cell-collection device. The company’s technology grew from a collaboration with Case Western Reserve University and is processed at Lucid Dx Labs, a CLIA-certified, CAP-accredited laboratory. Lucid also brings its screening directly to at-risk communities through mobile testing units and firefighter screening events.New York, NY